Shanghai ChemPartner appoints new VP and Head of Biology and Pharmacology

ChemPartner has announced the appointment of Yinfei Yin, Ph.D. as vice president of and head of the biology and pharmaco...

June 22, 2023 | Thursday | News
Pistoia Alliance partners with Matador to enable pharma R&D in Japan

The Pistoia Alliance, a global, not-for-profit alliance that advocates for greater collaboration in life sciences R&...

June 20, 2023 | Tuesday | News
US-based startup Cullgen inks billion-dollar deal with Japanese pharma firm Astellas

Japan-headquartered Astellas Pharma and US-based startup Cullgen have entered into a research collaboration and exclusiv...

June 19, 2023 | Monday | News
China's Everest Medicines appoints new Chief Technology Officer

China-based Everest Medicines, a biopharmaceutical company focused on development, manufacturing and commercialisation o...

June 16, 2023 | Friday | News
China's growth as pharmaceutical hub for APIs to continue

The first thing to say about the pharmaceutical market in general in China is that with the market now opening-up, busin...

June 9, 2023 | Friday | Opinion
Korea's Samsung Biologics and Pfizer partner for long-term manufacturing of biosimilars portfolio

South Korea-based Samsung Biologics and American pharma firm Pfizer have recently announced a strategic partnership aime...

June 9, 2023 | Friday | News
Australia drives digital transformation of biopharma sector with new ARC Hub

A new Australian Research Council (ARC) Hub to help forge an internationally competitive Australian biopharmaceutica...

June 12, 2023 | Monday | News
Taiwan-based Lotus Pharma inks $350 M deal for bipolar depression treatment

Taiwan-based Lotus Pharmaceuticals, and American firms Alvogen and NRx Pharmaceuticals have entered into a global collab...

June 9, 2023 | Friday | News
US-based Rani Therapeutics expands biologics partnership with Korean firm Celltrion

Rani Therapeutics Holdings, a clinical-stage biotherapeutics company focused on the oral delivery of biologics and drugs...

June 8, 2023 | Thursday | News
Colorcon invests in new pharma-based film coating manufacturing plant in Malaysia

US-headquartered Colorcon, Inc. has announced its investment in a new manufacturing plant in Johor State, Malaysia&...

June 7, 2023 | Wednesday | News
CPHI events report strong performance in Asia

The CPHI series of pharma events, the largest exhibitions in pharma, have seen significant growth in Asia in the first h...

June 7, 2023 | Wednesday | News
Malaysia approves Australian pharma firm Starpharma's antiviral nasal spray Viraleze

Australian pharma firm Starpharma has achieved regulatory approval for its antiviral nasal spray product, Viraleze,...

June 6, 2023 | Tuesday | News
InDex Pharma inks $50 M deal with Viatris Japan treatment of ulcerative colitis

Swedish firm InDex Pharmaceuticals Holding AB has announced that a license agreement has been signed with Viatris Pharma...

June 1, 2023 | Thursday | News
India's Sun Pharma inks new deal to commercialise skin cancer drug in Europe, Australia and New Zealand

India-based Sun Pharmaceutical Industries and Swiss-Italian biotech firm Philogen S.p.A have entered into a licensing ag...

May 31, 2023 | Wednesday | News
“Bringing a drug to market successfully goes beyond proving its efficacy in treating a particular disease”

What are some of your key areas of focus in R&D and what’s your approach toward pharma innovation?  Kyow...

May 31, 2023 | Wednesday | Opinion
Pharmapack Awards 2024 open for entries

The influential Pharmapack Awards 2024 are open for submissions (entry deadline 31st August, 20...

May 25, 2023 | Thursday | News
CPHI & PMEC China 2023 to see surge from pent up international ingredients demand

CPHI & PMEC China will open in June (19-21st) at the Shanghai New International Expo Center as international au...

May 25, 2023 | Thursday | News
US FDA approves first oral anti-viral for treatment of COVID-19 in adults

The US Food and Drug Administration (FDA) has approved the oral anti-viral Paxlovid (nirmatrelvir tablets and ritonavir ...

May 26, 2023 | Friday | News
IMCD Malaysia buys Euro Chemo-Pharma to accelerate growth in life science markets

IMCD N.V., a leading distributor, formulator, and solutions provider of speciality chemicals and ingredients headquarter...

May 22, 2023 | Monday | News
China approves two COVID-19 vaccine trials against most recent circulating XBB variants

Recombinant bivalent COVID-19 protein vaccine (Sf9 cells) and recombinant trivalent COVID-19 trimeric protein vaccine (S...

May 22, 2023 | Monday | News
US-based startup KSQ inks immuno-oncology deal worth $510 M with Japan's Takeda Pharma

US-based startup KSQ Therapeutics has expanded its strategic collaboration with Japanese pharmaceutical firm Takeda to r...

May 19, 2023 | Friday | News
DxVx appoints Yong Gu Lee as new CEO and Kevin Kwon as new president

South Korea's DxVx has appointed Yong Gu Lee as the new Chief Executive Officer (CEO) and Kevin Kwon, the former head of...

May 17, 2023 | Wednesday | News
Japan's Astellas Pharma enters into cancer research collaboration with Sony Corporation

Japan headquartered Sony Corporation and Astellas Pharma Inc. have entered into a collaborative research agree...

May 17, 2023 | Wednesday | News
Venus Remedies bolsters position in oncology space with marketing approval from Philippines, Iraq

Close on the heels of the marketing approval for a key cancer drug from the UK Medicines and Healthcare products Re...

May 9, 2023 | Tuesday | News
Japan's Eisai inks $2 B oncology deal with China-based startup Bliss Biopharma

Japanese pharmaceutical firm Eisai Co. has entered into a joint development agreement with China-based startup Bliss Bio...

May 8, 2023 | Monday | News